1. Home
  2. CVGW vs NGEN Comparison

CVGW vs NGEN Comparison

Compare CVGW & NGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calavo Growers Inc.

CVGW

Calavo Growers Inc.

HOLD

Current Price

$24.87

Market Cap

463.3M

ML Signal

HOLD

NGEN

NervGen Pharma Corp. Common stock

N/A

Current Price

$4.36

Market Cap

412.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CVGW
NGEN
Founded
1924
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Specialty Foods
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
463.3M
412.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CVGW
NGEN
Price
$24.87
$4.36
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$33.50
N/A
AVG Volume (30 Days)
672.5K
185.4K
Earning Date
01-14-2026
04-02-2026
Dividend Yield
3.21%
N/A
EPS Growth
N/A
N/A
EPS
1.11
N/A
Revenue
$648,434,000.00
N/A
Revenue This Year
$13.89
N/A
Revenue Next Year
$11.67
N/A
P/E Ratio
$22.49
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.40
$1.50
52 Week High
$28.72
$6.30

Technical Indicators

Market Signals
Indicator
CVGW
NGEN
Relative Strength Index (RSI) 64.96 18.54
Support Level $24.22 $5.02
Resistance Level $27.54 $5.70
Average True Range (ATR) 0.88 0.38
MACD 0.10 -0.12
Stochastic Oscillator 55.79 18.65

Price Performance

Historical Comparison
CVGW
NGEN

About CVGW Calavo Growers Inc.

Calavo Growers Inc is engaged in the sourcing, packing, and distribution of fresh avocados, tomatoes, and papayas, and the processing of guacamole and other avocado products. The company delivers products to retail grocers, club and mass-merchandise stores, foodservice operators, and wholesalers, sourcing avocados from California, Mexico, and other key growing regions. Its operations include sorting, packing, ripening, and shipping fresh produce, and processing and packaging fresh and frozen guacamole. The company operates through two segments: Fresh, including avocados, tomatoes, papayas, and other fresh produce products, and Prepared, including guacamole and avocado pulp, with the majority of revenue generated from the Fresh segment and geographically from the United States.

About NGEN NervGen Pharma Corp. Common stock

NervGen Pharma Corp is a clinical-stage biotech company. The company's principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291 and NVG-300.

Share on Social Networks: